Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
1. 请及时下载文件确认是否正确, 系统将在 2025-10-21 09:46:05 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S0140-6736(23)00772-9
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0140673623007729
其他信息:
出版社: Elsevier BV
作者: Arvind Dasari; Sara Lonardi; Rocio Garcia-Carbonero; Elena Elez; Takayuki Yoshino; Alberto Sobrero; James Yao; Pilar García-Alfonso; Judit Kocsis; Antonio Cubillo Gracian; Andrea Sartore-Bianchi; Taroh Satoh; Violaine Randrian; Jiri Tomasek; Geoff Chong; Andrew Scott Paulson; Toshiki Masuishi; Jeremy Jones; Tibor Csőszi; Chiara Cremolini; Francois Ghiringhelli; Ardaman Shergill; Howard S Hochster; John Krauss; Ali Bassam; Michel Ducreux; Anneli Elme; Laurence Faugeras; Stefan Kasper; Eric Van Cutsem; Dirk Arnold; Shivani Nanda; Zhao Yang; William R Schelman; Marek Kania; Josep Tabernero; Cathy Eng
